Paola Facheris

18PUBLICATIONS
62CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMajor global burdens of diseaseAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|Jun 26, 2026
Dose Adjustment of JAK Inhibitors for the Management of Moderate-to-Severe Atopic Dermatitis: A Single-Centre Retrospective Study.

|Apr 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.

|Apr 09, 2026
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.

Francesco D'Oria, Francesco Piscazzi, Paola Facheris

|Jun 27, 2025
OX40 and Regulatory Marker Alterations in Lesional and Non-Lesional Keloid Tissues.

Jonathan Bar, Eden David, Ester Del Duca

Pageof 3

Frequent Collaborators

7 joint publications

Mario Valenti

7 joint publications

Emma Guttman-Yassky

5 joint publications

Luigi Gargiulo

5 joint publications

Ester Del Duca